EcoDrugPlus

Ensembl ID : ENSAPEG00000003262
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSAPEG00000024656
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSAPEG00000024654
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSAPEG00000024722
Gene Symbol: RPL18A
1 Cross references
366 Possible Orthologues:

Ensembl ID : ENSAPEG00000024678
Gene Symbol: RPL18A
1 Cross references
366 Possible Orthologues:

Ensembl ID : ENSAPEG00000011222
Gene Symbol: -
Cross references: -
306 Possible Orthologues:

Ensembl ID : ENSAPEG00000011267
Gene Symbol: -
Cross references: -
1085 Possible Orthologues:

Ensembl ID : ENSAPEG00000011352
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSAPEG00000024628
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSAPEG00000013828
Gene Symbol: -
Cross references: -
261 Possible Orthologues:

Ensembl ID : ENSAPEG00000024114
Gene Symbol: SLC22A6L
1 Cross references
360 Possible Orthologues:

Ensembl ID : ENSAPEG00000023942
Gene Symbol: -
Cross references: -
171 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).